Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
YAFO Capital is a Shanghai-based boutique investment and advisory firm focused on cross-border transactions in biopharma, medtech, and broader healthcare. The firm operates through advisory, fund investment, incubation, and industry forum activities, helping bring global healthcare technologies into China and other Asian markets. YAFO Life Sciences, its sector-focused advisory business, specializes in licensing, financing, and partnering transactions for novel drug and medical device assets. The company appears to function primarily as a healthcare-focused financial and strategic advisory platform rather than a drug developer, so it does not have a conventional therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on YAFO Capital.